palmidrol has been researched along with Atrophy in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Argenio, G | 1 |
Petrosino, S | 1 |
Gianfrani, C | 1 |
Valenti, M | 1 |
Scaglione, G | 1 |
Grandone, I | 1 |
Nigam, S | 1 |
Sorrentini, I | 1 |
Mazzarella, G | 1 |
Di Marzo, V | 1 |
1 other study available for palmidrol and Atrophy
Article | Year |
---|---|
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.
Topics: Adolescent; Adult; Amides; Animals; Arachidonic Acids; Atrophy; Cannabinoid Receptor Modulators; Cas | 2007 |